The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric

NCT05956847 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-08-29

No results posted yet for this study

Summary

ECDNA is almost non-existent in normal cells, but exists in nearly half of human cancer cells, indicating that studying such abnormal DNA is of great significance for our understanding of tumor formation and evolution. The changes in ecDNA expression in intestinal type gastric cancer may be closely related to the occurrence and development of gastric cancer. Dynamic monitoring of changes in ecDNA expression in the gastric mucosa may help predict the occurrence of gastric cancer and guide subsequent treatment. By collaborating with multiple endoscopic centers to conduct gastroscopy biopsies on patients with gastric precancerous lesions, we aim to further explore the role of ecDNA in the occurrence and development of gastric cancer through continuous follow-up.

Conditions

  • Gastric Cancer
  • Precancerous Lesion of Digestive Tract
  • Extrachromosomal DNA

Interventions

PROCEDURE

gastroscopy

When performing gastroscopy, the endoscopist will perform a biopsy based on the condition of gastric mucosal lesions, with one specimen retained and the remaining specimens subjected to pathological examination

Sponsors & Collaborators

  • Yuncheng Central Hospital

    collaborator OTHER
  • Xi'an Honghui Hospital

    collaborator OTHER
  • Xi'an No.9 Hospital

    collaborator UNKNOWN
  • Xi'an No.3 Hospital

    collaborator OTHER_GOV
  • Xijing 986 Hospital

    collaborator UNKNOWN
  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Guo Xin · Xijing 986 Hospital

  • Wang Tongfei · Xi'an No.3 Hospital

  • Hao Junfeng · Xi'an No.9 Hospital

  • Shi Yupeng · Xi'an Honghui Hospital

  • Gao Xiaopeng · Yuncheng Central Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-10
Primary Completion
2028-07-20
Completion
2030-07-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05956847 on ClinicalTrials.gov